Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B

The aim of the present study was to evaluate the effects of switching to tenofovir alafenamide (TAF) in patients who had received a nucleos(t)ide analog (NA) for the treatment of chronic hepatitis B (CHB). The data from 33 Japanese patients with CHB who received TAF therapy after using NA [adefovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Sano, Tomoya, Amano, Keisuke, Ide, Tatsuya, Kawaguchi, Toshihiro, Kuwahara, Reiichiro, Arinaga-Hino, Teruko, Koga, Hironori, Kuromatsu, Ryoko, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678628/
https://www.ncbi.nlm.nih.gov/pubmed/33235727
http://dx.doi.org/10.3892/br.2020.1388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678628/
https://www.ncbi.nlm.nih.gov/pubmed/33235727
http://dx.doi.org/10.3892/br.2020.1388

Ejemplares similares